Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Submitted by
admin
on January 19, 2012 - 10:38am
Source:
Bloomberg
News Tags:
AstraZeneca
FDA
Bristol-Myers Squibb
diabetes
Dapagliflozin
Headline:
Bristol, AstraZeneca Diabetes Drug Fails to Win FDA Backing
Do Not Allow Advertisers to Use My Personal information
